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Abstract
Objective: The aim of the present study was to test the association between psychosocial factors and
delay in uptake of treatment and treatment non-adherence in Indonesian women with breast cancer.
Methods: Seventy consecutive patients with breast cancer who were treated at the Hasan Sadikin
Hospital in Indonesia were recruited. They completed a demographic form, the non-adherence
questionnaire, the Breast Cancer Knowledge Test, the Brief Illness Perception Questionnaire, the
Multidimensional Health Locus of Control Scales, the Satisfaction with Cancer Information Proﬁle
and the Distress Thermometer.
Results: Seventeen (24%) out of 70 patients reported that they had delayed initiating treatment at
the hospital, and nine (13%) out of 70 patients had missed two or more consecutive treatment sessions.
In the bivariate analyses, we found no signiﬁcant differences on any of the psychological variables
between patients who delayed initiating treatment and those patients who did not, whereas patients
who had missed two or more consecutive sessions had lower satisfaction with the type and timing of
information provided and more negative illness perceptions than patients who had not missed their
sessions. In multivariate regression analyses, consulting a traditional healer before diagnosis was
associated with treatment delay (β = 1.27, p= 0.04). More negative illness perceptions (β = 0.10,
p= 0.02) and whether a traditional healer had been consulted after diagnosis (β = 1.67, p= 0.03) were
associated with missing treatment sessions.
Conclusions: Indonesian health professionals need to be aware of patients’ negative illness
perceptions and their unrealistic belief in traditional healers.
Copyright © 2014 John Wiley & Sons, Ltd.
Introduction
Breast cancer is the most frequently diagnosed cancer
among women both in developed and developing countries
[1]. In Indonesia, breast cancer has emerged as the most
frequent cancer and the leading cause of death, with an inci-
dence rate of 36.2 and a mortality rate of 18.6 per 100,000
people [2,3]. A review study of cancer epidemiology in
South-East Asian countries found that late presentation at
the hospital for treatment was the major problem related to
lower survival rates among women with breast cancer in
Indonesia [4]. In addition, poor adherence to treatment is
considered to be an important factor contributing to higher
mortality rates in developing countries [5].
Non-adherence to treatment may appear in several forms:
(a) not attending or coming late to appointments, (b) delay
or not initiating a recommended treatment, (c) not complet-
ing behavioral recommendations, (d) not taking medication
as prescribed, and (e) terminating the treatment prematurely
[6]. A meta-analysis study about patient adherence that
involved 569 published studies found an average non-
adherence rate of 25% and a non-adherence rate of 21%
for cancer patients [7]. Speciﬁcally among breast cancer
population, previous studies found about 16–32% of pa-
tients delayed initiating treatment [8,9], and approximately
30% of patients discontinued therapy early [10]. Our
retrospective qualitative study in 50 breast cancer patients
in Indonesia found that 42% had delayed the uptake of
treatment at the hospital and 20% had missed two or more
consecutive sessions during their treatment [11]. In a
study among Indonesian childhood leukemia patients,
approximately 25% of patients refused or abandoned
therapy [12]. A study in Indonesian retinoblastoma
patients found that 31.5% of patients temporarily refused
medical treatment, whereas 18.2% of patients refused
treatment permanently [13].
In general, psychosocial factors of non-adherence to
treatment can be differentiated into three groups: cognitive,
social, and emotional variables. Cognitive variables include
patients’ knowledge, risk perception, beliefs, and attitude to
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breast cancer treatment, whereas social variables include
social networks and social support [14]. Previous studies
among breast cancer patients found that greater knowledge
of the disease and treatment is associated with better
adherence [15–17]. A review study of patients’ illness
perceptions and medication adherence found that negative
illness perceptions were directly or indirectly associated
with poor adherence to medication [18]. Patients’ beliefs
about disease (e.g., having cancer is a fate) and treatment
(e.g., use of alternative medicine) were related to delay in
seeking help for oral, breast, and cervix symptoms
[19,20]. A review study about adherence to therapy with
oral anti-neoplastic agents suggested that people with a
strong belief that their behavior played a large role in deter-
mining their circumstances (internal locus of control) are
more likely to adhere to a prescribed treatment regimen
[21]. With regard to social variables, a meta-analysis study
about social support and patient adherence to medical
treatment found that better social support was associated
with better adherence [22]. Another meta-analysis found
that high levels of psychological distress were associated
with poor adherence [23].
In our previous qualitative study, consecutive samples of
50 breast cancer patients were interviewed. We identiﬁed
several psychosocial factors related to delay in seeking help
and non-adherence to treatment, including, lack of aware-
ness and knowledge, cancer beliefs, treatment beliefs,
emotional burden, and unmet information needs [11]. The
aim of the present study was to test the association between
these psychosocial factors (i.e., knowledge, illness percep-
tion, health locus of control, satisfaction with information,
and distress) and delay in uptake of treatment and treatment
non-adherence in Indonesian breast cancer patients.
Methods
Participants
This study was part of a larger investigation in which the psy-
chosocial aspects of 120 Indonesian breast cancer patients
who were undergoing medical treatment (i.e., surgery,
chemotherapy, and radiotherapy) at the outpatient surgical
oncology clinic at Hasan Sadikin Hospital (HSH) in Ban-
dung urban area were explored in two phases. The ﬁrst group
of 50 consecutive patients was recruited between April and
June 2010, and the second group of 70 consecutive patients
was recruited between June and October 2011 (the current
study). The study included patients who were aged 18 years
or older, had received a ﬁrst diagnosis of breast cancer, had
no psychiatric treatment history, and had an adequate
command of the Indonesian language.
Procedures
This study was approved by the Indonesian medical
ethical committee and the Board of Directors of HSH.
First, we translated the relevant questionnaires, namely, the
Breast Cancer Knowledge Test (BCKT), the Brief Illness
Perception Questionnaire (BIPQ), the Multidimensional
Health Locus of Control Scales (MHLC), the Satisfaction
with Cancer Information Proﬁle (SCIP), and the Distress
Thermometer (DT), using the forward and back translation
method. One of the authors of this study (A. I.), who is a clin-
ical psychologist, translated the questionnaires from English
into the Indonesian language; the back translation into
English was carried out by an English language teacher
(J.H.) who is a Native American and speaks the Indonesian
language ﬂuently. Upon completing the translation, a linguist
(A.C.) examined the original English version and the
back translation version of the questionnaires to assess the
signiﬁcance of any discrepancies. After some discussions
with A.C., we ﬁnalized the Indonesian version of the
questionnaires. A panel of experts (i.e., three Indonesian
psychologists) assessed the content validity of the version.
They reviewed the items of each questionnaire and
commented on whether the items covered a representative
sample of the behavior domain.
Second, eligible patients were approached by a member
of the administration staff from the surgical oncology
clinic. They asked patients for initial consent and referred
patients who were willing to participate in the study to the
research assistants. One of the research assistants followed
up and arranged an appointment with the patients on their
next visit. All data collections were conducted by 10
master’s students in clinical psychology who were trained
as research assistants and were supervised by A. I. (ﬁrst au-
thor) and S. S. (ﬁfth author). After signing the informed con-
sent, patients were asked to complete a socio-demographic
form, the non-adherence questionnaire, the BCKT, the
BIPQ, the MHLC, the SCIP, and the DT. For those
who were unable to complete the questionnaires unassisted
(i.e., seven patients were illiterate), the research assistants
read the questionnaires aloud and recorded the patients’
answers on the questionnaires. Patients ﬁlled in the
questionnaires in the waiting room of the clinic before their
consultation with the physicians.
Measures
Socio-demographic characteristics
A standard socio-demographic form was used to collect self-
report data on age, marital status, education, employment
status, family income, insurance status, travel time to hospi-
tal, time since diagnosis, family history of cancer, and use
of traditional healer. The patients’ medical records were
also reviewed to obtain data on type and stage of cancer
and type of treatment.
Adherence to treatment
Patients’ adherence to treatment was assessed using a self
report. We evaluated two forms of non-adherence: (1)
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treatment delay and (2) not attending treatment appoint-
ments. As there is a strong association between delaying
breast cancer treatment by 3 months or more and lower
survival [24], we adopted a 3-month interval as our gold
standard for treatment delay. A patient was categorized as
a non-adherer according to the ﬁrst deﬁnition if the period
between the ﬁrst diagnosis and the ﬁrst admission at HSH
was>3 months. A patient was categorized as a non-adherer
according to the second deﬁnition if they were absent from
two or more consecutive treatment sessions at HSH [25].
Breast cancer knowledge
Patient knowledge was assessed using the BCKT [26].
This instrument comprises two sections: the ﬁrst section
consists of 12 items to assess individual breast cancer
general knowledge, and the second section consists of eight
items to assess individual knowledge about the curability of
breast cancer. For each item, patients were asked to mark
whether the statement is ‘true’ or ‘false’. Items correctly
answered are given a score of 1, and items answered incor-
rectly are given a score of 0. In the ﬁrst section, item number
3 about the breast cancer prevalence was adjusted with the
actual Indonesian prevalence rate. The total score ranged
from 0 to 20, with higher scores indicating higher breast
cancer knowledge. The BCKT has an acceptable reliability
coefﬁcient (α=0.69).
Illness perceptions
Patient’s cognitive and emotional representation of illness
was assessed using the BIPQ [27]. This instrument was
constructed on the basis of the Common Sense Model of
Illness Cognition, which assumes that illness perceptions
will have an effect on patients’ coping behaviors and psy-
chological outcomes [28]. Illness perceptions consists of
eight dimensions: (1) consequences, which reﬂect the
expected effects and outcome of the illness; (2) time line,
which refers to the perceived duration of the illness; (3)
personal control, which reﬂects the beliefs about personal
abilities to control the illness; (4) treatment control, which
reﬂects the beliefs about the efﬁcacy of the treatment to
cure or manage the illness; (5) identity, which refers to
the label the person uses to describe the illness and the
symptoms; (6) illness concern, which refers to how much
the person worries about his/her illness; (7) coherence,
which refers to how well the person understands his/her
illness; and (8) emotional representation, which reﬂects
a person’s evaluation of the potential emotional impact
of the illness [27]. Each dimension is measured by a single
item using a continuous linear 0–10 point scale. Answer
scales of items about personal control, treatment control,
and coherence were reversed to elicit the same response
directions with the other ﬁve items. The overall score
was obtained by summing the eight item scores where a
higher score indicates a more threatening view of the ill-
ness. Cronbach’s alpha coefﬁcient of the BIPQ is 0.70.
Internal health locus of control
The internal health locus of control (HLC) was assessed
using the internal HLC subscale of the MHLC Scales [29].
The MHLC was developed as a generic medical condi-
tion-speciﬁc measurement of locus of control that assesses
individuals’ feelings of control over their illness or disease,
including the internal, chance, doctors, and powerful others
subscales. This measure is an 18-item scale using a 6-point
Likert format, ranging from 1= ‘strongly disagree’ to
6 = ‘strongly agree’. A higher score on each subscale is
indicative of a stronger inﬂuence of the dimension in health
behaviors. Cronbach’s alpha coefﬁcients of the MHLC
scales ranged from 0.48 to 0.77.
Satisfaction with cancer information
Patient satisfaction with the information provided was
assessed using the SCIP [30]. This measure comprises two
subscales: subscale 1 consists of 14 items that measure
patient satisfaction with the amount and content of informa-
tion. Patients are asked to rate each item using the following
response scale: ‘too much’, ‘about right’, ‘too little’, and
‘none wanted’. Patients who rate the items with either
‘about right’ or ‘none wanted’ are given a score of 1,
whereas patients who rate the items with either ‘too much’
or ‘too little’ are given a score of 0. A subscale total score
is obtained by summing the score for each item, which
ranged from 0 to 14. High scores indicating a high degree
of satisfaction with the amount and content of information
received. Subscale 2 consists of seven items that measure
patient satisfaction with the type and timing of information
received. Patients are asked to rate each item on a ﬁve-
response scale ranged from ‘very satisﬁed’=5 to ‘very
dissatisﬁed’=0. The total subscale score ranged from 7 to
35, with higher scores indicating higher levels of satisfac-
tion with the form and timing of information. The reliability
coefﬁcient for the Indonesian version of the SCIP was good
(subscale 1 α=0.77 and subscale 2 α=0.81).
Psychological distress
Psychological distress was assessed using the DT [31].
The DT was developed by the NCCN and is a one-item
self-report measure of psychological distress in patients
with cancer. Patients are asked to report their distress in
the past week on a thermometer-like 11-point visual
analog scale, with scores ranging from 0 (no distress) to
10 (extreme distress).
Data analysis
All data analyses were performed using the IBM® SPSS®
Statistics version 20. Descriptive statistics were used to
Non-adherence to treatment in Indonesian women with breast cancer
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describe the demographic and clinical information, the mean
scores of the questionnaires (i.e., the BCKT, the BIPQ, the
MHLC, the SCIP, and the DT), and the non-adherence status.
To explore the association between non-adherence and the
demographic, clinical, and psychological variables, chi-
square analyses were conducted for categorical variables,
and t-test analyses were conducted for continuous variables.
Backward stepwise logistic regression analyses were
performed to analyze the association between psychosocial
variables and non-adherence. The BCKT, the BIPQ, the
Internal HLC, the SCIP, and the DT scores were the
predictors, whereas treatment delay and not attending
treatment appointment were the outcomes. In addition,
backward stepwise logistic regression analyses were
performed to explore the association between demo-
graphic and clinical characteristics and non-adherence.
Age, marital status, education level, employment status,
family incomes, travel time to hospital, and consult
a traditional healer before and after diagnosis were
the predictors, whereas treatment delay and not attend-
ing treatment appointment were the outcomes. For
the logistic regression of not attending treatment
appointments, current stage of cancer was also included
as a predictor. A power calculation for 70 cases with
six predictors in a linear regression analysis showed
that a medium effect (f 2 = 0.21) should exist in
the population in order to ﬁnd a signiﬁcant effect
(p = 0.05) [32].
Results
Demographic and clinical characteristics
The mean age of participants was 45.6 years (SD= 7.88,
range = 28–66). Fifty-seven (81%) participants were
married, and 46 (66%) participants were unemployed/
housewives. The majority of participants had a lower edu-
cation level (junior high school = 16% and elementary
school = 51%). Fifty-three (76%) participants had a low
monthly income (<$200), and 28 (40%) had a travel time
from home to the hospital>3 hours. Almost half of partic-
ipants had an advanced stage of cancer (stage III = 23%
and stage IV = 20). Demographic and clinical variables
are summarized in Table 1.
Non-adherence to treatment
Treatment delay
Seventeen (24%) out of 70 patients had delayed initiating
treatment at HSH with a time delay ranging from 3 to 27
months, except for the two participants who had delayed
treatment for 4 years. The median time of treatment delay
was 7 months. In regard to demographic and clinical
characteristics, we found that the stage of cancer and
consulting a traditional healer before diagnosis were
associated with treatment delay. Patients who delayed
initiating treatment were more likely to be at an advanced
cancer stage (stage III and IV) (χ2 = 9.244, df=3, p=0.03)
and had more frequently consulted a traditional healer be-
fore their diagnoses (χ2 = 4.953, df= 1, p=0.03). Means,
standard deviations, and range of the psychological
variable scores are detailed in Table 2. The t-test results
showed no signiﬁcant differences on any of the
psychological variables between patients who delayed
initiating treatment and who did not. Backward stepwise
logistic regression analyses found that consulting a tradi-
tional healer before diagnosis was the only signiﬁcant
predictor of treatment delay (β = 1.27, p = 0.04).
Table 1. Demographic and clinical characteristics of study
participants
Variable n (%)
Age (M±SD) 45.60± 7.88
Marital status
Married 57 (81%)
Single 2 (3%)
Widowed 11 (16%)
Education (highest)
None 7 (10%)
Elementary school 36 (51%)
Junior high school 11 (16 %)
Senior high school 10 (14 %)
College or university 6 (9%)
Employment
Housewife/unemployed 46 (66%)
Laborer/irregular job 18 (26%)
Private employee 1 (2%)
Government ofﬁcer 5 (7%)
Family income (monthly)
<$200 53 (76%)
$200–$300 13 (18%)
>$300 4 (6%)
Travel time to hospital
<1 h 22 (31%)
2–3 h 20 (29%)
>3 h 28 (40%)
Months since diagnosis (M±SD) 22.6± 19.7
Range (months) 1–84
Current stage of cancer
1 3 (4%)
2 37 (53%)
3 16 (23%)
4 14 (20%)
Treatment modality
Mastectomy 32 (46%)
Chemotherapy 51 (73%)
Radiotherapy 12 (17%)
Health insurance
Yes 66 (94%)
No 4 (6%)
Family history of breast cancer
Yes 14 (20%)
No 56 (80%)
Consult a traditional healer
Before diagnosis 33 (47%)
After diagnosis 12 (17%)
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Not attending treatment appointments
Nine (13%) out of 70 patients reported that they had missed
two or more consecutive treatment sessions. In regard to de-
mographic and clinical characteristics, we found that only
consulting a traditional healer after diagnosis was associated
with missing two or more consecutive treatment sessions
(χ2 = 5.420, df=1, p=0.02). Means, standard deviations,
and range of the psychological variable scores are detailed
in Table 2. The t-test results showed that patients who had
missed two or more consecutive sessions had lower satisfac-
tion with the type and timing of information provided
(t=2.247, p=0.03) and more negative illness perceptions
(i.e., a more threatening view of cancer) (t=2.520,
p=0.01) than patients who had not missed two or more con-
secutive sessions. Backward stepwise logistic regression
analyses found that illness perception (β =0.10, p=0.02)
was the only signiﬁcant psychological predictor of missing
two or more consecutive treatment sessions. Post hoc logistic
regression analysis showed that only treatment control di-
mension signiﬁcantly predicted missing treatment sessions
(β =0.39, p=0.03). In addition, consulting a traditional
healer after diagnosis (β =1.67, p=0.03) was a signiﬁcant
demographic predictor of missing two or more consecutive
treatment sessions.
Discussion
The present study showed that 24% of breast cancer
patients reported that they had delayed initiating treatment
at the hospital and 13% of breast cancer patients had
missed two or more consecutive treatment sessions. In
the bivariate analyses, we found that patients who had
missed two or more consecutive sessions had lower satis-
faction with the type and timing of information provided
and more negative illness perceptions than patients who
had not. In multivariate regression analyses, consulting a
traditional healer before diagnosis was associated with
treatment delay. Having more negative illness perceptions
and consulting a traditional healer after diagnosis were
associated with missing two or more consecutive treatment
sessions. Contrary to our expectations, patients’ level of
knowledge, internal HLC, and distress were associated with
neither treatment delay nor missing treatment sessions.
Of the 70 patients who were currently receiving treatment
for their breast cancer, 24% reported that they delayed initi-
ating treatment after their diagnosis, which is lower than our
previous study that found 40% delayed initiating treatment
[11]. One possible explanation for this difference may be re-
lated to the clinical characteristics of the patients. We found
that the majority of patients (57%) in the current study were
at stage I and II and therefore probably had more positive
expectations; whereas in the previous study, the majority
of patients (64%) were at stage III and IV. Nevertheless, this
ﬁnding was higher than a recent study in South-East Asian
breast cancer patients that found 7% of patients delayed
initiating treatment at the hospital [33]. Thirteen percent of
patients were non-adherent to treatment by missing two or
more consecutive treatment sessions. The current non-
adherence rate was lower than a previous study among
Nigerian breast cancer patients, which used a similar deﬁni-
tion of non-adherence as the current study. Approximately
80% of patients missed two consecutive doses of chemo-
therapy. Financial problems, fear of operation, and a strong
belief in traditional healers were the most frequent reasons
for non-adherence to treatment [25].
Having more negative illness perceptions was associated
with missing treatment sessions. These results are in concor-
dance with the result of a recent review study that found a
negative association between illness perception and adher-
ence to medication [18]. According to the Common Sense
Model of Illness, patients create cognitive and emotional
representations of the illness as responses to symptoms and
signs of illness, and those perceptions will lead to their
coping responses [27]. In this study, we found that a low be-
lief in treatment efﬁcacy is associated with missing treatment
sessions, which is similar to previous studies ﬁndings among
diabetes and hypertension patients that found patients who
felt treatment could control their illness were more likely to
take their medication as prescribed [34,35].
Table 2. Means, standard deviations, and t-test results of the psychological variables of the non-adherers and the adherers group
Measure
Initiating a recommended treatment Attending appointments
Adherers Non-adherers Adherers Non-adherers
(n=53) (n= 17) n=61 n=9
Mean (SD) Mean (SD) t-test p-value Mean (SD) Mean (SD) t-test p-value
Distress 4.58 (2.76) 4.82 (2.60) 0.315 0.75 4.46 (2.66) 5.89 (2.80) 1.495 0.14
Internal health locus of control 24.57 (4.18) 23.59 (4.53) 0.823 0.41 23.97 (4.08) 26.78 (4.84) 1.885 0.06
Satisfaction with the amount and content of information 5.40 (3.50) 4.76 (2.75) 0.679 0.50 5.34 (3.28) 4.56 (3.75) 0.662 0.51
Satisfaction with the form and timing of information 23.23 (4.07) 21.47 (4.11) 1.544 0.13 23.21 (3.89) 20 (4.72) 2.247 0.03
Illness perception 38.51 (9.35) 39.94 (13.25) 0.414 0.68 37.70 (10.26) 46.67 (7.35) 2.520 0.01
Breast cancer knowledge 9.42 (4.16) 8.82 (4.16) 0.582 0.56 9.18 (3.63) 9.89 (3.79) 0.544 0.59
SD, standard deviation.
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In bivariate analyses, lower satisfaction with informa-
tion provided was found to be associated with missing
treatment sessions. This ﬁnding is in line with previous
literature, which found that greater satisfaction with
information was associated with higher adherence to med-
ical recommendations and treatments [36,37]. However,
this association was not signiﬁcant in multivariate analy-
ses. One possible explanation for this result is a high col-
linearity between illness perception and satisfaction with
information (r=0.35, p< 0.01); therefore, multivariate
analyses showed only the strongest predictor (i.e., illness
perceptions) of missing treatment sessions.
We found that consulting a traditional healer before
diagnosis was a risk factor for treatment delay and con-
sulting a traditional healer after diagnosis was a risk factor
for missing treatment sessions. This ﬁnding supports the
results of our previous study that identiﬁed a strong belief
in traditional healers as one of the main barriers of non-
adherence to treatment [11].
Several methodological limitations should be noted.
First, this study is based on consecutive patients where the
majority has low socio-economic status because HSH is a
referral hospital for the poor people. The relatively small
sample size and homogeneity of the current sample could
have some inﬂuence on the results. For example, a review
study of 50 years of research about adherence to medical
recommendations found that studies with smaller sample
sizes reported higher adherence than larger samples [7].
Therefore, the adherence rate obtained in this study should
be interpreted with caution and may not represent the
general Indonesian cancer patient population. Second,
non-adherence was measured through patients’ self report
in a retrospective way. Therefore, patients’ responses were
vulnerable to recall and social desirability bias, which may
have resulted in an underestimation of non-adherence.
Lastly, the cross-sectional design of the study limits the
causal association between psychological factors and non-
adherence to treatment. Moreover, the psychological vari-
ables were measured after the occurrence of non-adherence,
and patients’ knowledge and distress at the time of measure-
ment may not have been the same as at the time of non-
adherence. Thus, further prospective studies are needed to
ascertain the current study ﬁndings.
Our study sheds light on the importance of illness
perceptions and the belief in traditional healers in explaining
non-adherence to treatment. The relative importance of
these factors should be studied in future prospective studies.
Our results suggest that health professionals need to be
aware of patients’ threatening view of cancer and its
medical treatment, and their unrealistic belief in traditional
healers. If they provide patients with clear information
about their illness and its treatment, patients’ misunder-
standing and negative conceptualization of the illness might
be eliminated, which in turn may lead to better adherence to
medical treatment[38].
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